The serum-ascites albumin gradient, or SAAG, is a lab value calculated by subtracting the albumin concentration in ascitic fluid from the albumin concentration in blood serum. A SAAG of 1.1 g/dL or higher indicates that portal hypertension is driving the fluid accumulation, while a value below 1.1 g/dL points toward causes unrelated to portal hypertension. This single number replaced an older and less reliable classification system and remains the first-line tool for sorting out why fluid has collected in someone’s abdomen.
Why Ascites Forms in the First Place
Ascites is the abnormal buildup of fluid in the peritoneal cavity, the space between the abdominal wall and the organs. In cirrhosis, which accounts for the majority of cases, the process begins with rising pressure in the portal venous system. As the liver becomes scarred, blood flow through it meets increasing resistance, and portal pressure climbs.1PubMed Central. Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis That elevated pressure triggers widening of the arteries supplying the gut and other abdominal organs, a phenomenon called splanchnic vasodilation. The body reads this vasodilation as a drop in effective blood volume and responds by ramping up sodium and water retention through hormonal pathways, essentially trying to fill a vascular system that has become too roomy.2PubMed. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites
At the same time, the high portal pressure and low albumin levels common in advanced liver disease disturb the balance of forces that normally keep fluid inside blood vessels. Lymph production in the splanchnic circulation increases, and eventually the peritoneal cavity cannot reabsorb fluid fast enough to keep up.3PubMed. Mechanisms of ascites formation The combined result is persistent sodium retention and fluid sequestration in the abdomen.4PubMed. Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour
How SAAG Replaced the Old Classification
For decades, doctors categorized ascitic fluid as either a “transudate” (low protein, suggesting a passive pressure-related leak) or an “exudate” (high protein, suggesting inflammation or malignancy). The cutoff was typically a total protein of 2.5 g/dL in the fluid. The problem was that this system got things wrong almost half the time. Cardiac ascites, for instance, is caused by heart failure raising venous pressure, which should make it a transudate, but the fluid often has a high protein concentration and would be misclassified as an exudate. Infected ascitic fluid in cirrhosis, expected to look like an exudate, frequently had low total protein. One landmark study found the old protein-based method classified ascites correctly only about 56% of the time.5PubMed. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites
SAAG solved this by focusing on the albumin difference between serum and ascitic fluid rather than on the total protein in the fluid alone. Because albumin is the main determinant of oncotic pressure, the gradient reflects the pressure difference between the portal capillaries and the peritoneal cavity. The same study showed that SAAG correctly identified whether portal hypertension was present about 97% of the time.6PubMed. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites Earlier work had already demonstrated that the albumin gradient was large (averaging about 1.6 g/dL) in pressure-driven ascites and small (about 0.6 g/dL) in inflammatory or malignant ascites, with highly significant separation between the two groups.7The American Journal of Medicine. Superiority of the serum-ascites albumin difference over the ascites total protein concentration in separation of “transudative” and “exudative” ascites The older total protein approach is now considered outdated, and SAAG has been the standard initial test for evaluating new-onset ascites for decades.8PubMed Central. Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites
What a High SAAG Means
A SAAG at or above 1.1 g/dL tells you that portal hypertension is present, with roughly 97% accuracy. The most common cause by far is cirrhosis, but the list also includes heart failure (both right-sided and congestive), Budd-Chiari syndrome (hepatic vein occlusion), and massive liver metastases that obstruct outflow. Essentially, anything that raises the pressure gradient between portal blood and the peritoneal space will push the SAAG above 1.1.
An interesting question is whether a higher SAAG value signals more severe portal hypertension. One study divided cirrhotic patients into three tiers of SAAG and found that esophageal varices and gastropathy were present at very high rates in all groups, including those with SAAG values just above the 1.1 cutoff. The relationship between the specific SAAG number and the degree of portal hypertensive changes was weak, meaning a SAAG of 2.5 does not necessarily indicate worse portal hypertension than a SAAG of 1.3.9PubMed Central. The Evaluation of Serum Ascites Albumin Gradient and Portal Hypertensive changes in Cirrhotic Patients with Ascites In clinical practice, SAAG is treated as a binary test: above or below 1.1. Trying to read much into the exact number beyond that threshold does not reliably guide decisions.
One area where the total protein in ascitic fluid still plays a role alongside SAAG involves distinguishing cardiac ascites from cirrhotic ascites. Both produce a high SAAG, since both involve portal or hepatic venous hypertension. But in heart failure without cirrhosis, the ascitic fluid tends to have a higher protein concentration. A study comparing cardiac cirrhosis patients with non-cirrhotic cardiac patients found that an ascitic fluid protein level at or below 4.3 g/dL predicted the presence of cirrhosis with 95% sensitivity.10PubMed. Characterization of ascites in cardiac cirrhosis: the value of ascitic fluid protein to screen for concurrent cardiac cirrhosis So while SAAG tells you portal hypertension exists, the total protein level can still help you narrow down the specific cause within the high-SAAG category.
What a Low SAAG Means
A SAAG below 1.1 g/dL points away from portal hypertension and toward causes that irritate or infiltrate the peritoneal lining. In a large review spanning seven years, tuberculous peritonitis was the most frequent cause of low-gradient ascites, accounting for about 46% of cases, followed by cancer at about 42%.11PubMed Central. Low gradient ascites: a seven-year course review Among the malignant cases, peritoneal carcinomatosis (cancer spread to the peritoneal lining) was most common, with ovarian and gastric cancers being the leading types. Other low-SAAG causes include nephrotic syndrome, pancreatitis, and serositis from autoimmune conditions.
Tuberculous peritonitis deserves special mention because it is notoriously hard to diagnose. Cultures of ascitic fluid for tuberculosis are positive in only a minority of cases, and staining for acid-fast bacilli is even less sensitive. One study found culture positivity in just 25% of confirmed cases, with smear and PCR testing of the fluid being essentially useless.12PubMed Central. Utility of Ascitic Fluid Adenosine Deaminase Levels in the Diagnosis of Tuberculous Peritonitis in General Medical Practice The fluid typically shows a high white cell count with a predominance of lymphocytes, and a low SAAG.13PubMed Central. Peritoneal tuberculosis mimicking peritoneal carcinomatosis Adenosine deaminase (ADA) levels in the ascitic fluid have emerged as a practical workaround: an ADA level at or above 40 IU/L showed 100% sensitivity and 96% specificity for peritoneal tuberculosis in one cohort, making it a strong screening tool in regions where TB is common.14PubMed Central. Utility of Ascitic Fluid Adenosine Deaminase Levels in the Diagnosis of Tuberculous Peritonitis in General Medical Practice
When SAAG Gets It Wrong
No test is perfect, and SAAG has recognized blind spots. The most clinically important is the false-negative result: someone with genuine portal hypertension whose SAAG dips below the 1.1 cutoff. This happens most often when serum albumin is extremely low. If your blood albumin is, say, 1.0 g/dL, the mathematical ceiling for SAAG is 1.0 regardless of how high the portal pressure is. A systematic review noted that false-negative SAAG values can occur in patients with portal hypertension and severe hypoalbuminemia, particularly in advanced cirrhosis.15Gut and Liver. Diagnostic Performance of Serum-Ascites Albumin Gradient: A Systematic Review and Meta-Analysis
Mixed ascites is another challenge. A patient with cirrhosis who also develops peritoneal tuberculosis or cancer has two simultaneous causes of fluid accumulation. In these mixed cases, the SAAG tends to stay high, resembling ordinary portal hypertensive ascites, because the portal pressure component dominates the albumin gradient.16The American Journal of Medicine. Superiority of the serum-ascites albumin difference over the ascites total protein concentration in separation of “transudative” and “exudative” ascites The peritoneal disease can be masked, delaying diagnosis. Research on ascitic cholesterol levels as a supplementary test has shown some promise: in patients misclassified by SAAG alone, ascitic cholesterol correctly identified the non-portal-hypertensive component about 69% of the time and performed well at detecting peritoneal lesions in mixed ascites.17PubMed. Ascitic cholesterol is superior to serum-ascites albumin gradient in the detection of non-portal hypertensive ascites and the diagnosis of mixed ascites
Spontaneous Bacterial Peritonitis
One of the most dangerous complications of ascites in cirrhosis is spontaneous bacterial peritonitis (SBP), an infection of the ascitic fluid that occurs without an obvious intra-abdominal source like a perforated organ. SBP develops because the immune defenses in cirrhotic ascitic fluid are impaired and bacteria can cross from the gut into the peritoneal cavity through the intestinal wall.
The standard diagnostic criterion is an ascitic fluid neutrophil count of 250 cells per cubic millimeter or higher, even when cultures come back negative.18PubMed Central. Characteristics of ascitic fluid from patients with suspected spontaneous bacterial peritonitis in emergency units at a tertiary hospital The neutrophil count matters because cultures of ascitic fluid miss a substantial number of infections. Clinical guidelines emphasize that the polymorphonuclear cell count is essential not just for diagnosing SBP but also for monitoring the response to antibiotic treatment.19PubMed Central. Ascitic fluid analysis for diagnosis and monitoring of spontaneous bacterial peritonitis Delayed treatment worsens outcomes significantly, so when SBP is suspected, antibiotics are started before waiting for cultures.
Managing High-SAAG Ascites
For portal-hypertensive ascites caused by cirrhosis, first-line management is sodium restriction and diuretics. Guidelines recommend limiting dietary sodium to roughly 80 to 120 mmol per day and starting spironolactone, an aldosterone antagonist, at 40 mg daily with stepwise increases up to 400 mg if needed. Patients who do not lose enough weight or continue retaining sodium get a loop diuretic, typically furosemide at 40 to 160 mg daily, added to the spironolactone.20PubMed Central. Guidelines on the management of ascites in cirrhosis The goal is gradual fluid mobilization; losing weight too quickly risks kidney injury and electrolyte problems.
When ascites no longer responds to maximum diuretic doses or when side effects make diuretics intolerable, it is classified as refractory. These patients typically need large-volume paracentesis (LVP), a procedure in which several liters of fluid are drained from the abdomen through a needle. LVP provides immediate relief but triggers a circulatory reflex: the sudden decompression of the splanchnic vessels causes further vasodilation, a drop in effective blood volume, and a hormonal cascade that leads to rapid reaccumulation of fluid, kidney injury, and sometimes encephalopathy.21PubMed Central. Pathophysiology and Prevention of Paracentesis-induced Circulatory Dysfunction: A Concise Review To prevent this postparacentesis circulatory dysfunction, intravenous albumin is given during the procedure. A meta-analysis of randomized trials found that albumin reduced the odds of this complication compared with alternative volume expanders like dextran or gelatin.22PubMed. Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials
Management of low-SAAG ascites is entirely different and depends on the underlying cause: anti-tuberculosis therapy for peritoneal TB, chemotherapy or surgery for malignancy, and treatment of the primary disease in cases like nephrotic syndrome or pancreatitis.23Clinics in Liver Disease. MANAGEMENT OF ASCITES Diuretics and sodium restriction are generally not effective when portal hypertension is absent, which is why SAAG plays such a pivotal role in pointing treatment in the right direction.
TIPS for Refractory Ascites
Transjugular intrahepatic portosystemic shunt (TIPS) is a procedure that creates a channel within the liver connecting the portal vein to a hepatic vein, effectively relieving portal pressure. For patients with refractory ascites who need repeated paracentesis, TIPS offers a more durable solution. A meta-analysis found that TIPS significantly improved transplant-free survival compared with repeated paracentesis, with a roughly 39% reduction in the risk of death. It also dramatically reduced the recurrence of ascites and lowered the risk of hepatorenal syndrome.24PubMed Central. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis
A more recent multicenter study reinforced these findings, reporting one-year overall survival of about 78% in the TIPS group versus about 47% in patients managed with paracentesis plus albumin. The need for further paracentesis dropped from 100% to about 18% in the TIPS group. The trade-off, however, was a substantially higher rate of hepatic encephalopathy: roughly 27% after TIPS compared with about 6% with paracentesis.25PubMed Central. TIPS improves survival in patients with cirrhosis and recurrent ascites: a multicenter observational study Encephalopathy happens because the shunt diverts portal blood, including toxins that the liver would normally filter, directly into the systemic circulation. Careful patient selection is important: people with advanced liver failure or pre-existing encephalopathy are less likely to benefit.
Even with TIPS, ascites elimination is not always complete. One study found that the need for paracentesis was entirely eliminated in about a third of patients, reduced by at least half in another third, and only modestly reduced in the rest.26Journal of Vascular and Interventional Radiology. Transjugular Intrahepatic Portosystemic Shunt Creation for Refractory Ascites: Efficacy and Long-Term Survival Analysis So TIPS should be thought of as a way to meaningfully reduce the burden of ascites rather than a guaranteed cure.
The Prognostic Weight of Ascites
The appearance of ascites in someone with cirrhosis is more than a symptom management problem; it marks a shift in prognosis. The development of ascites is generally considered a turning point in the natural history of the disease, carrying a mortality risk of about 40% at one year and 50% at two years.27Exploration of Digestive Diseases. Ascites in cirrhotic patients: a comprehensive review This is why new-onset ascites in a cirrhotic patient prompts not only a SAAG measurement and a management plan, but also a conversation about liver transplant evaluation. Refractory ascites carries an even grimmer outlook, which is part of the rationale for pursuing TIPS or transplant rather than indefinite paracentesis.
Automated Pumps and Newer Approaches
For patients who cannot receive TIPS and are not transplant candidates, repeated paracentesis every few weeks becomes the default. That cycle is burdensome and associated with recurrent circulatory stress. A newer device called the alfapump offers an alternative: it is a small battery-powered pump implanted under the skin that continuously moves ascitic fluid from the peritoneal cavity into the urinary bladder, where it is eliminated through normal urination.28PubMed Central. Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites The slow, continuous drainage is designed to avoid the abrupt circulatory swings seen with large-volume paracentesis.29Egyptian Liver Journal. Advancements in ascites management: a comprehensive narrative review of the Alfa Pump system Early clinical experience has been encouraging, though device-related complications like urinary tract infections and pump malfunctions remain concerns. The alfapump is available in parts of Europe but is not yet widely adopted. It occupies a niche between repeat paracentesis and TIPS for a specific subset of patients who have run out of other options, and ongoing studies continue to refine its role.